Fulton Breakefield Broenniman’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.86M Buy
177,115
+11,493
+7% +$251K 0.23% 65
2026
Q1
$3.63M Buy
165,622
+11,221
+7% +$247K 0.24% 66
2025
Q4
$3.41M Buy
154,401
+4,145
+3% +$91.7K 0.22% 65
2025
Q3
$3.33M Buy
150,256
+11,017
+8% +$242K 0.22% 65
2025
Q2
$3.06M Buy
139,239
+74,066
+114% +$1.6M 0.21% 65
2025
Q1
$1.42M Buy
65,173
+28,577
+78% +$614K 0.1% 82
2024
Q4
$782K Buy
36,596
+14,368
+65% +$311K 0.06% 97
2024
Q3
$493K Buy
22,228
+6,637
+43% +$145K 0.03% 116
2024
Q2
$331K Buy
15,591
+3,822
+32% +$80.7K 0.02% 140
2024
Q1
$252K Buy
+11,769
New +$252K 0.02% 159

Other funds holding IBDV

Fulton Breakefield Broenniman's IBDV Position: Q2 2026 in Review

Fulton Breakefield Broenniman increased its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 6.9% in Q2 2026, buying an estimated $251K and bringing the position to 177,115 shares worth $3.86M. The position accounts for 0.23% of the portfolio, ranked #65.

Fulton Breakefield Broenniman first reported a position in IBDV in Q1 2024 and has held it in 10 quarters since. 349 funds tracked by Wall St. Rank hold IBDV as of Q2 2026.

  • Fulton Breakefield Broenniman held 177,115 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $3.86M as of Q2 2026.
  • Fulton Breakefield Broenniman bought 11,493 iShares iBonds Dec 2030 Term Corporate ETF shares in Q2 2026, an estimated $251K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 0.23% of Fulton Breakefield Broenniman's portfolio in Q2 2026, its #65 holding.
  • Fulton Breakefield Broenniman first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • 349 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q2 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.